Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting

Citation
Rj. Damiano et al., Initial prospective multicenter clinical trial of robotically-assisted coronary artery bypass grafting, ANN THORAC, 72(4), 2001, pp. 1263-1268
Citations number
14
Categorie Soggetti
Cardiovascular & Respiratory Systems","Medical Research Diagnosis & Treatment
Journal title
ANNALS OF THORACIC SURGERY
ISSN journal
00034975 → ACNP
Volume
72
Issue
4
Year of publication
2001
Pages
1263 - 1268
Database
ISI
SICI code
0003-4975(200110)72:4<1263:IPMCTO>2.0.ZU;2-R
Abstract
Background. This multicenter prospective trial was designed to assess the s afety and efficacy of using a robotically-assisted microsurgical system to create endoscopic coronary anastomoses. Methods. Thirty-two patients scheduled for elective primary coronary surger y underwent endoscopic anastomosis of the left internal thoracic artery (LI TA) to the left anterior descending (LAD) artery. Three thoracic ports (two for instruments and one for a camera) were placed, and a robotic system wa s used to perform the LITA-LAD graft. Conventional techniques were used to perform the other grafts. Thirty-one patients underwent median sternotomy a nd 1 patient underwent a limited anterior thoracotomy. Results. Graft flow was measured in the operating room and averaged 37 +/- 19 mL/min. Mean anastomosis time was 24 +/- 9 minutes. There were three int raoperative revisions (9%). Two were for inadequate flow and one for an ina dvertent injury. Each of these grafts was successfully revised by hand. The re were no technical failures of the robotic system. Average postoperative length of stay was 5.5 +/- 2.7 days. There were three reoperations for blee ding, but none of these were related to the LAD anastomosis. Two months fol lowing the operation, selective angiography revealed a graft patency of 93% . The patients have been followed for 16 +/- 4 months. Conclusions. This initial prospective multicenter trial documents the feasi bility of robotically-assisted coronary bypass grafting. Further trials are warranted to establish the safety and efficacy of this new technology. (C) 2001 by The Society of Thoracic Surgeons.